Year 4
BCVA: 20/25
Choroidal hypertransmission defect indicative of atrophy.
Thank you for signing up!
You should receive a welcome email in your inbox shortly.
You are now leaving RecognizeAndReferGA.com
This link will take you to another Apellis Pharmaceuticals, Inc. website.
Are you a US eye care professional?